About Us Direct to You Research Archives Currencies Shares Media
Monitoring Home

PRODUCT PROFILE

Latest Dublin Prices

NAME	LATEST	CHANGE
Aer Lingus	1.60	0.00	more
BoI	0.19	0.01	more
CRH	16.70	-0.28	more
Elan	9.25	0.05	more
Glanbia	10.87	-0.01	more
Grafton	5.58	-0.01	more
Greencore	0.64	-0.02	more
Ind. News	0.12	0.01	more
Ryanair	6.74	-0.03	more

Shares in full

Boston Sci post weaker results in Q4

Tuesday, January 29 12:32:24

Boston Scientific today posted weaker quarterly earnings as sales slipped and expenses rose.

Fourth-quarter net earnings were $60 million, or 4 cents per share, down from $107 million, or 7 cents per share, in the year-earlier period.

Excluding items, earnings were 11 cents per share, matching the average estimate on Wall Street, according to Thomson Reuters I/B/E/S. There were fewer outstanding shares used to compute per share earnings in the latest period.

Quarterly sales dipped to $1.82 billion from $1.85 billion a year earlier on weakness in its key markets from implantable heart devices.

Business World is a service of Media World Ltd. All rights reserved. While every effort has been made to ensure the accuracy of the data provided, neither Media World Ltd nor its agents or representatives will be responsible for any loss or damage on the part of users however caused. The service is for entertainment only, and no decisions, particularly investment decisions, should be taken on the basis of information supplied in the service.